Bristol-Myers Squibb (BMY) Tops Q4 EPS by 1c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $54.70 +1.30%
Revenue Growth %: -4.6%
Financial Fact:
Net Earnings Attributable to Noncontrolling Interest: 13M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -4.6%
Financial Fact:
Net Earnings Attributable to Noncontrolling Interest: 13M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $1.83, $0.01 better than the analyst estimate of $1.82. Revenue for the quarter came in at $12 billion versus the consensus estimate of $12.12 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2022 EPS of $7.65-$7.95.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
- Worried the AI trade has gone too far? Evercore likes these 4 stocks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
